Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression
Name
Gao-2011-Deletion of the de n.pdf
Size
1.32 MB
Format
Adobe PDF
Checksum (MD5)
a4401247bcf0da43656affb55b6d0c10
Author(s) • • • • • • • •
Gao, Qing
Steine, Eveline J.
Barrasa, M. Inmaculada
Hockemeyer, Dirk
Pawlak, Mathias
Fu, Dongdong
Reddy, Seshamma
Bell, George W.
Jaenisch, Rudolf
Date Issued
October 2011
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Citation
Gao, Q. et al. “Deletion of the De Novo DNA Methyltransferase Dnmt3a Promotes Lung Tumor Progression.” Proceedings of the National Academy of Sciences 108.44 (2011): 18061–18066. Copyright ©2011 by the National Academy of Sciences
Version
Final published version
Abstract
Alterations in DNA methylation have been associated with genome-wide hypomethylation and regional de novo methylation in numerous cancers. De novo methylation is mediated by the de novo methyltransferases Dnmt3a and 3b, but only Dnmt3b has been implicated in promoting cancer by silencing of tumor-suppressor genes. In this study, we have analyzed the role of Dnmt3a in lung cancer by using a conditional mouse tumor model. We show that Dnmt3a deficiency significantly promotes tumor growth and progression but not initiation. Changes in gene expression show that Dnmt3a deficiency affects key steps in cancer progression, such as angiogenesis, cell adhesion, and cell motion, consistent with accelerated and more malignant growth. Our results suggest that Dnmt3a may act like a tumor-suppressor gene in lung tumor progression and may be a critical determinant of lung cancer malignancy.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Whitehead Institute for Biomedical Research
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.1114946108